QUANTICA
10.11.2022 11:46:41 CET | Business Wire | Press release
Last November at the international additive manufacturing exhibition Formnext, Quantica announced its T1 Pro, an R&D system that showcased the company’s multi-material, ultra-high viscosity jetting capabilities, known as NovoJet™. A year later, Quantica is back at the Frankfurt-based expo, this time introducing a new Desktop system– the NovoJet™ C-7.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221110005047/en/
The Berlin-based 3D printing start-up is pushing the boundaries of multi-material and high-performance material jetting, through the introduction of the NovoJet™ C-7. A printer suitable for research, feasibility studies, and small scale production of custom applications. It will be made available to research institutes and industry partners, looking to develop high-performance, multi-material 3D printing and other additive manufacturing applications.
NovoJet™ C-7 is an open printing platform, ideal for 2D and 3D application development using Quantica’s ultra-high viscosity jetting technology. It has been created for research institutes, R&D labs, and organizations looking to develop new additive manufacturing materials and workflows. Beyond feasibility testing and application development, the printer can also be used for customized and low-volume production, enabling a truly seamless transition from lab to production.
Key features of the NovoJet™ C-7 include:
- Material Experimentation: The system uses printheads capable of handling a wide range of fluids with viscosities exceeding 380mPa•s at jetting temperature, equating to approximately 4000mPa•s at ambient temperature. Along with experimentation with liquids with high particle loading.
- New Material Combinations: The system has the ability to control up to 7 material channels giving users access to new material combinations with better mechanical properties, color fidelity, and aesthetics.
- System Customization: The system offers customizable integrations for research and development needs.
The power of Quantica’s NovoJet™ printhead technology is its ability to print materials that are 15 times more viscous than legacy inkjet printheads. This opens up new possibilities for delivering high value end-part products with properties such as high toughness, temperature resistance, conductivity, biocompatibility, and flexibility manufactured in a single process.
Multiple industry partners, mainly within the dental, medical and electronics space, have started collaborations with Quantica to develop targeted solutions based on the novel capabilities.
“This new system unlocks enormous possibilities for the material deposition industries, giving material developers the ability to move past the limitations of low performance fluids and start developing new formulations with better properties of interest. In the end, we empower organizations to build products in new and exciting ways,” said Ramon Borrell, CTO of Quantica. “Quantica is already exploring several applications in the dental, healthcare, consumer goods, and electronics industries. We are excited to support these, and the many other, industries in breaking down current inkjet barriers and limitations.”
For more information about the NovoJet™ C-7, please visit https://quantica3d.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005047/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Special Olympics Airlift Takes Flight Nationwide; Dove 1 Arrives at St. Paul Downtown Airport19.6.2026 17:09:00 CEST | Press release
Approximately 130 Cessna, Beechcraft and Hawker aircraft and volunteer pilots mobilize to transport more than 800 Special Olympics athletes and coaches to the 2026 Special Olympics USA Games The 2026 Special Olympics Airlift officially took flight today as all participating Cessna, Beechcraft and Hawker aircraft, known as Doves, departed from airports across the country. Dove 1 for arrival day, a Cessna Citation Latitude generously operated by Prent Corporation, landed at St. Paul Downtown Airport (STP) carrying Special Olympic athletes and delegation members, signaling the start of Airlift arrivals for the Special Olympics USA Games. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619085293/en/ Special Olympics Airlift takes flight nationwide; Dove 1 arrives at St. Paul Downtown Airport (Photo credit: Textron Aviation). The arrival signals the start of the world’s largest cumulative peacetime airlift spanning more than 40
Record Currency Management Participates in Innovative European Bank for Reconstruction and Development (EBRD) -Backed Mongolian Tugrik Transaction19.6.2026 16:53:00 CEST | Press release
Record Currency Management Ltd (RCM), subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce its participation in an innovative local currency bond transaction issued by the European Bank for Reconstruction and Development (EBRD), supporting the development of Mongolia's capital markets while providing institutional investors with access to attractive frontier market opportunities. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group managing USD 115 billion of assets on behalf of institutional clients worldwide. Record's client base comprises pension funds, foundations, sovereign institutions and other asset managers, with whom the Group has built long-standing relationships through its focus on bespoke investment and risk management solutions. Headquartered in London, Record has offices in Hamburg, Zurich, Zug, New York, and Hong Kong. The investment forms part of Record Financial Group's broad
Plasma One Launches to Herald a New Era of Stablecoin Banking19.6.2026 14:29:00 CEST | Press release
Plasma has today announced the launch of Plasma One, its flagship financial product designed to make digital dollars usable for everyday spending, sending and earning. Plasma One is designed to make stablecoins feel like money, only better - more accessible, reliable and efficient. For years, stablecoin adoption has been held back by a fragmented system and poor user experience. We have seen wallets in one place, exchanges in another, and costly off-ramps standing between digital dollars and daily life. Plasma One brings that experience together in a single app, giving users a simple way to spend, send and earn with stablecoins from one account with zero fees. Headquartered in London, the city that gave rise to Revolut, Wise and Monzo, Plasma is making a bigger bet, that the next generation of consumer banking will be built on stablecoin rails, not legacy banking infrastructure. Underneath Plasma One is the Plasma Network, Plasma’s own blockchain, purpose-built to move stablecoins inst
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release
Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom